<?xml version="1.0" encoding="UTF-8"?>
<ref id="B26">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hussain</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Khan</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Jan</surname>
    <given-names>M. S.</given-names>
   </name>
   <name>
    <surname>Ahmad</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Ahmad</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Rashid</surname>
    <given-names>U.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2019</year>). 
  <article-title>Synthesis, 
   <italic>in-vitro</italic> Î±-glucosidase inhibition, antioxidant, 
   <italic>in-vivo</italic> antidiabetic and molecular docking studies of pyrrolidine-2, 5-dione and thiazolidine-2, 4-dione derivatives
  </article-title>. 
  <source>Bioorg. Chem.</source>
  <volume>91</volume>:
  <fpage>103128</fpage>. 
  <pub-id pub-id-type="doi">10.1016/j.bioorg.2019.103128</pub-id>
  <?supplied-pmid 31369977?>
  <pub-id pub-id-type="pmid">31369977</pub-id>
 </mixed-citation>
</ref>
